The Safety and Performence of ShockPulse-10 in Patients with Coronary Artery Calcification

Recruiting N/A Interventional Study
Coronary Arterial Disease (CAD) Calcification; Heart
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
205 (estimated)
Sponsor
Keya Medical · Industry
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This study is an exploratory, multicenter, single-group clinical trial aimed to evaluate the clinical outcomes of using ShockPulse-10 in the treatment of coronary artery calcification .

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Key Inclusion Criteria: 1. Patient is ≥ 18 years of age; 2. Patients with significant coronary artery disease (including stable or unstable angina and asymptomatic myocardial ischemia) who are suitable for PCI treatment; 3. A single newly developed stenosis of the target vessel, which is the left a…
Contacts

XIANTAO SONG, Dortor

010-64412431

Song0929@mail.ccmu.edu.cn

CONTACT